title: CRMP-5-IgG in patient with paraneoplastic optic neuritis with lung adenocarcinoma.
authors.forename: Y
authors.initials: Y
authors.lastname: Murakami
authors.forename: S
authors.initials: S
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Yoshikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaji
authors.forename: Y
authors.initials: Y
authors.lastname: Ikeda
authors.forename: A
authors.initials: A
authors.lastname: Ueno
authors.forename: T
authors.initials: T
authors.lastname: Ishibashi
mesh_terms: D000230:Adenocarcinoma / Q000150:complications*; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D006867:Hydrolases; D007074:Immunoglobulin G / Q000097:blood; D008175:Lung Neoplasms / Q000150:complications*; D008869:Microtubule-Associated Proteins; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000276:immunology; D009902:Optic Neuritis / Q000175:diagnosis*; D010257:Paraneoplastic Syndromes / Q000175:diagnosis*
chemical_list: D014408:Biomarkers, Tumor; D007074:Immunoglobulin G; D008869:Microtubule-Associated Proteins; D009419:Nerve Tissue Proteins; C415087:DPYSL5 protein, human; D006867:Hydrolases